Acute myeloid leukaemia trials in China

In China 226 Also abroad 763

226 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML
Where
Kunming
Age
18 years to 65 years
People
291
Run by
The Second Affiliated Hospital of Kunming Medical University
See details and how to joinNCT07712848
Early phase 1Not yet taking people in China
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia
Where
Guangzhou
Age
3 years to 75 years
People
18
Run by
Zhujiang Hospital
See details and how to joinNCT07696481
Phase 1/2Taking people
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Where
Guanzhou
Age
18 years to 60 years
People
40
Run by
Zhujiang Hospital
See details and how to joinNCT05270200
Phase 1Taking people
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
Where
Suzhou
Age
18 years to 74 years
People
18
Run by
Imbioray (Hangzhou) Biomedicine Co., Ltd.
See details and how to joinNCT06234904
Phase 1Taking people
Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Where
Nanchang
Age
18 years to 70 years
People
18
Run by
iCell Gene Therapeutics
See details and how to joinNCT07668557
Phase 2Not yet taking people in China
Study on the Efficacy and Safety of VA Regimen Compared to "3+7" Regimen in Newly Diagnosed AML With NPM1 or IDH1/IDH2 Mutations
Where
Shanghai
Age
18 years to 65 years
People
148
Run by
Shen yang
See details and how to joinNCT07664839
Phase 1/2Taking people
Luspatercept for CIA in AML
Where
Guangzhou
Age
18 years to 60 years
People
40
Run by
Guangdong Second Provincial General Hospital
See details and how to joinNCT07663864
Phase 2/3Enrolling by invitation
Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
Where
Hangzhou
Age
15 years to 65 years
People
450
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07651163
Phase 2/3Enrolling by invitation
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
Where
Hangzhou
Age
18 years to 65 years
People
267
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07651176
Phase 2Not yet taking people in China
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
Where
Suzhou
Age
18 years to 65 years
People
180
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07575412
No phaseTaking people
Haplo-Cord HSCT for AML/MDS
Where
Beijing, Chengdu, Fuzhou, Guangzhou
Age
14 years to 60 years
People
82
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07588360
No phaseNot yet taking people in China
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
Where
Suzhou
Age
18 years and over
People
50
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07635485
No phaseTaking people
Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
Where
Hangzhou
Age
8 years to 18 years
People
600
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07450872
Phase 1Taking people
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
Where
Beijing
Age
18 years to 70 years
People
27
Run by
Peking University People's Hospital
See details and how to joinNCT07617285
Phase 2Taking people
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS
Where
Shanghai
Age
18 years and over
People
20
Run by
Ruijin Hospital
See details and how to joinNCT07607418
Phase 1Taking people
Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
Where
Beijing, Chengdu, Shanghai
Age
1 year to 70 years
People
27
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06326021
Phase 1/2Taking people
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Where
Hanzhou
Age
18 years and over
People
133
Run by
Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT05133882
Phase 2/3Taking people
VABu Conditioning in Elderly AML HSCT
Where
Suzhou
Age
60 years and over
People
20
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07583888
Phase 1/2Taking people
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Where
Tianjin
Age
14 years and over
People
23
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06611839
Phase 2Taking people
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
Where
Tianjin
Age
14 years to 60 years
People
380
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06635681
Phase 1/2Taking people
Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
Where
Shenzhen
Age
18 years to 75 years
People
10
Run by
Shenzhen University General Hospital
See details and how to joinNCT07584889
Phase 2Taking people
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
Where
Beijing
Age
14 years to 75 years
People
160
Run by
Chinese PLA General Hospital
See details and how to joinNCT06928376
Phase 1Taking people
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
Where
Fuzhou
Age
18 years to 70 years
People
90
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07551037
Phase 4Taking people
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
Where
Fuzhou
Age
18 years to 65 years
People
100
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07561892
Phase 2Not yet taking people in China
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
Where
Suzhou
Age
15 years to 60 years
People
160
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07562568